Inventor · disambiguated record
Harald Schmidt
Also filed as: SCHMIDT HARALD · SCHMIDT HARALD HORST HEINZ WILHELM
9 granted patents·6 pending applications·112 citations·filing 1973–2023
87Inventor score
Top patents by PatentIndex Score
15 records- 0189US4011233A2-methyl-2-(4-methyl-3-pentene-1-yl) thiazolidineGIVAUDAN CORP·Filed 1975·Granted Mar 8, 1977·18 cites·1 claims
- 0285US6844343B1N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agentVASOPHARM BIOTECH GMBH·Filed 2000·Granted Jan 18, 2005·37 cites·9 claims
- 0368US5902810APteridine derivatives as no synthase inhibitorsHOECHST AG·Filed 1995·Granted May 11, 1999·27 cites·13 claims
- 0464US8236809B2Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activationTEGTMEIER FRANK·Filed 2005·Granted Aug 7, 2012·2 cites·6 claims
- 0561US2023265359A1Compositions containing biosurfactants and a lipase from stachybotrys chlorohalonataEVONIK OPERATIONS GMBH·Filed 2023·Application pending·0 cites
- 0661US2025281485A1Diagnosis and/or treatment of heart failure with preserved ejection fractionUNIV MAASTRICHT·Filed 2023·Application pending·0 cites
- 0759US2023228764A1Method for the diagnosis and treatment of essential primary hypertensionUNIV MAASTRICHT·Filed 2021·Application pending·0 cites
- 0858US6858612B1Use of tetrahydropteridine derivatives as no synthase inhibitorsVASOPHARM BIOTECH GMBH·Filed 1999·Granted Feb 22, 2005·15 cites·23 claims
- 0956US2024349730A1Dried biological compositions and methods thereofEVONIK OPERATIONS GMBH·Filed 2022·Application pending·0 cites
- 1053US2023083417A1Therapeutic combination for the treatment of brain ischemia and said therapeutic combination for use in the treatment of brain ischemiaUNIV MAASTRICHT·Filed 2021·Application pending·0 cites
- 1145US6849438B1Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1)VASOPHARM BIOTECH GMBH·Filed 1999·Granted Feb 1, 2005·9 cites·8 claims
- 1245US2023087609A1USE OF A SOLUBLE GUANYLATE CYCLASE (sGC) STIMULATOR OR OF A COMBINATION OF A sGC STIMULATOR AND AN sGC ACTIVATOR FOR CONDITIONS WHEREIN THE HEME GROUP OF sGC IS OXIDIZED OR WHEREIN sGC IS DEFICIENT IN HEMEUNIV MAASTRICHT·Filed 2021·Application pending·0 cites
- 1341US5023232AMixtures of bicyclic ethers and fragrance compositions containing sameGIVAUDAN CORP·Filed 1989·Granted Jun 11, 1991·1 cites·4 claims
- 1435US3944561A2-Methyl-2-acetyl-thiazolidineGIVAUDAN CORP·Filed 1973·Granted Mar 16, 1976·3 cites·1 claims
- 1533US5185472AMixtures of bicyclic ethers, fragrance compositions containing same and novel intermediateGIVAUDAN CORP·Filed 1991·Granted Feb 9, 1993·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Harald Schmidt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →